Molecular events in primary and metastatic colorectal carcinoma: A review

Pathology Research International

Volumn 2012, Issue , 2012, Pages

  Kanthan, Rani ^a,b   Senger, Jenna Lynn ^a   Kanthan, Selliah Chandra ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b ROYAL UNIVERSITY HOSPITAL   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866235163     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2012/597497     Document Type: Article

References (74)

1. Colorectal Cancer Statistics at a Glance, 2011
2. Fearon E. R., Molecular genetics of colorectal cancer. Annual Review of Pathology 2011 6 479 507
3. Worthley D. L., Leggett B. A., Colorectal cancer: molecular features and clinical opportunities. The Clinical Biochemist Reviews 2010 31 2 31 39
4. Sengupta N., Gill K. A., MacFie T. S., Lai C. S., Suraweera N., Mcdonald S., Silver A., Management of colorectal cancer: a role for genetics in prevention and treatment? Pathology Research and Practice 2008 204 7 469 477 2-s2.0-46749158634 10.1016/j.prp.2008.03.003
5. Deschoolmeester V., Baay M., Specenier P., Lardon F., Vermorken J. B., A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist 2010 15 7 699 731 2-s2.0-77956103532 10.1634/theoncologist.2010-0025
6. Kahng L. S., Genetic aspects of non-polypoid colorectal neoplasms. Gastrointestinal Endoscopy Clinics of North America 2010 20 3 573 578 2-s2.0-77955064974 10.1016/j.giec.2010.03.004
7. Ogino S., Chan A. T., Fuchs C. S., Giovannucci E., Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2010 2-s2.0-77958534077 10.1136/gut.2010.217182
8. Markowitz S. D., Bertagnolli M. M., Molecular basis of colorectal cancer. New England Journal of Medicine 2009 361 25 2404 2460 2-s2.0-72449176846 10.1056/NEJMra0804588
9. Migliore L., Migheli F., Spisni R., Copped F., Genetics, cytogenetics, and epigenetics of colorectal cancer. Journal of Biomedicine and Biotechnology 2011 2011 19 792362 10.1155/2011/792362
10. Costedio M., Church J., Pathways of carcinogenesis are reflected in patterns of polyp pathology in patients screened for colorectal cancer. Diseases of the Colon & Rectum 2011 54 10 1224 1228 10.1097/DCR.0b013e3182270d7f
11. Fearon E. R., Vogelstein B., A genetic model for colorectal tumorigenesis. Cell 1990 61 5 759 767 2-s2.0-0025312728 10.1016/0092-8674(90) 90186-I (Pubitemid 20185636)
12. Boland C. R., Goel A., Microsatellite instability in colorectal cancer. Gastroenterology 2010 138 6 2073 e3 2-s2.0-77449130761 10.1053/j.gastro.2009.12. 064
13. Pino M. S., Chung D. C., The chromosomal instability pathway in colon cancer. Gastroenterology 2010 138 6 2059 2072 2-s2.0-77951627056 10.1053/j.gastro.2009.12.065
14. Perea J., Lomas M., Hidalgo M., Molecular basis of colorectal cancer: towards an individualized management. Revista Espanola de Enfermedades Digestivas 2011 103 1 29 35
15. Sillars-Hardebol A. H., Carvalho B., De Wit M., Postma C., Delis-Van Diemen P. M., Mongera S., Ylstra B., Van De Wiel M. A., Meijer G. A., Fijneman R. J. A., Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression. Tumor Biology 2010 31 2 89 96 2-s2.0-77951253958 10.1007/s13277-009-0012-1
16. Winder T., Lenz H. J., Molecular predictive and prognostic markers in colon cancer. Cancer Treatment Reviews 2010 36 7 550 556 2-s2.0-77957948992 10.1016/j.ctrv.2010.03.005
17. Goel A., Nagasaka T., Arnold C. N., Inoue T., Hamilton C., Niedzwiecki D., Compton C., Mayer R. J., Goldberg R., Bertagnolli M. M., Boland C. R., The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 2007 132 1 127 138 2-s2.0-33846192840 10.1053/j.gastro.2006.09.018 (Pubitemid 46108731)
18. Grady W. M., Carethers J. M., Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008 135 4 1079 1099 2-s2.0-53049087109 10.1053/j.gastro.2008.07.076
19. Ashktorab H., Schäffer A. A., Daremipouran M., Smoot D. T., Lee E., Brim H., Distinct genetic alterations in colorectal cancer. PLoS ONE 2010 5 1 2-s2.0-77749277159 10.1371/journal.pone.0008879 e8879
20. Dalton W. B., Yang V. W., Mitotic origins of chromosomal instability in colorectal cancer. Current Colorectal Cancer Reports 2007 3 2 59 64
21. Brenner B. M., Rosenberg D., High-throughput SNP/CGH approaches for the analysis of genomic instability in colorectal cancer. Mutation Research 2010 693 1-2 46 52 2-s2.0-78049415211 10.1016/j.mrfmmm.2010.04.002
22. Booth R. A., Minimally invasive biomarkers for detection and staging of colorectal cancer. Cancer Letters 2007 249 1 87 96 2-s2.0-33947309748 10.1016/j.canlet.2006.12.021 (Pubitemid 46437280)
23. Walther A., Houlston R., Tomlinson I., Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 2008 57 7 941 950 2-s2.0-46349086833 10.1136/gut.2007.135004 (Pubitemid 351919529)
24. Geiersbach K. B., Samowitz W. S., Microsatellite instability and colorectal cancer. Archives of Pathology & Laboratory Medicine 2011 125 1269 1277
25. Iacopetta B., Grieu F., Amanuel B., Microsatellite instability in colorectal cancer. Asia-Pacific Journal of Clinical Oncology 2010 6 4 260 269 2-s2.0-78649766938 10.1111/j.1743-7563.2010.01335.x
26. de la Chapelle A., Hampel H., Clinical relevance of microsatellite instability in colorectal cancer. Journal of Clinical Oncology 2010 28 20 3380 3387 2-s2.0-77954720070 10.1200/JCO.2009.27.0652
27. Yim K. L., Microsatellite instability in metastatic colorectal cancer: a review of pathology, response to chemotherapy and clinical outcome. Medical Oncology. In press
28. Raut C. P., Pawlik T. M., Rodriguez-Bigas M. A., Clinicopathologic features in colorectal cancer patients with microsatellite instability. Mutation Research 2004 568 2 275 282 2-s2.0-8144224215 10.1016/j.mrfmmm.2004.05.025 (Pubitemid 39473320)
29. Huang C. S., Farraye F. A., Yang S., O'Brien M. J., The Clinical Significance of Serrated Polyps. American Journal of Gastroenterology 2010 2-s2.0-77958523312 10.1038/ajg.2010.429
30. Jass J. R., Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007 50 1 113 130 2-s2.0-33845608798 10.1111/j.1365-2559.2006.02549.x (Pubitemid 44953403)
31. Snover D. C., Update on the serrated pathway to colorectal carcinoma. Human Pathology 2011 42 1 1 10 2-s2.0-78649985198 10.1016/j.humpath.2010.06.002
32. Bellizzi A. M., Frankel W. L., Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Advances in Anatomic Pathology 2009 16 6 405 417 2-s2.0-73949154143 10.1097/PAP.0b013e3181bb6bdc
33. Venkatachalam R., Ligtenberg M. J., Hoogerbrugge N., de Bruijn D. R., Kuiper R. P., Geurts van Kessel A., The epigenetics of (hereditary) colorectal cancer. Cancer Genetics and Cytogenetics 2010 203 1 1 6 2-s2.0-78049418172
34. Kim J. H., Shin S. H., Kwon H. J., Cho N. Y., Kang G. H., Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. Virchows Archiv 2009 455 6 485 494 2-s2.0-73449118889 10.1007/s00428-009-0857-0
35. Kim Y. S., Deng G., Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia. Gut and Liver 2007 1 1 1 11 10.5009/gnl.2007.1.1.1
36. Cheng Y. W., Pincas H., Bacolod M. D., Schemmann G., Giardina S. F., Huang J., Barral S., Idrees K., Khan S. A., Zeng Z., Rosenberg S., Notterman D. A., Ott J., Paty P., Barany F., CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. Clinical Cancer Research 2008 14 19 6005 6013 2-s2.0-58149166788 10.1158/1078-0432.CCR-08-0216
37. ARAIN.
38. Kang G. H., Four molecular subtypes of colorectal cancer and their precursor lesions. Archives of Pathology and Laboratory Medicine 2011 135 6 698 703
39. Melcher R., Hartmann E., Zopf W., Herterich S., Wilke P., Muller L., Rosler E., Kudlich T., Al-Taie O., Rosenwald A., Katzenberger T., Scholtka B., Seibold S., Rogoll D., Scheppach W., Scheurlen M., Lührs H., LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability. Carcinogenesis 2011 32 4 636 642 10.1093/carcin/bgr011
40. Huang D., Du X., Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination. World Journal of Gastroenterology 2008 14 12 1823 1827 2-s2.0-42149114501 10.3748/wjg.14.1823 (Pubitemid 351523810)
41. de Roock W., Biesmans B., De Schutter J., Tejpar S., Clinical biomarkers in oncology: focus on colorectal cancer. Molecular Diagnosis and Therapy 2009 13 2 103 114 2-s2.0-67650489071 10.2165/01250444-200913020-00003
42. Yachida S., Mudali S., Martin S. A., Montgomery E. A., Iacobuzio-Donahue C. A., Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation. American Journal of Surgical Pathology 2009 33 12 1823 1832 2-s2.0-73349134675 10.1097/PAS.0b013e3181b6da19
43. Fearnhead N. S., Britton M. P., Bodmer W. F., The ABC of APC. Human Molecular Genetics 2001 10 7 721 733 2-s2.0-0035057699 (Pubitemid 32331581)
44. van den Brink G. R., Linking pathways in colorectal cancer. Nature Genetics 2004 36 10 1038 1039 2-s2.0-6944244098 10.1038/ng1004-1038 (Pubitemid 41184461)
45. Lièvre A., Blons H., Laurent-Puig P., Oncogenic mutations as predictive factors in colorectal cancer. Oncogene 2010 29 21 3033 3043 2-s2.0-77952956887 10.1038/onc.2010.89
46. Asghar U., Hawkes E., Cunningham D., Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer. Clinical Colorectal Cancer 2010 9 5 274 281 10.3816/CCC.2010.n.040
47. Slaby O., Svoboda M., Michalek J., Vyzula R., MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Molecular Cancer 2009 8 102 2-s2.0-71049136170 10.1186/1476-4598-8-102
48. de Krijger I., Mekenkamp L. J. M., Punt C. J. A., Nagtegaal I. D., MicroRNAs in colorectal cancer metastasis. Journal of Pathology 2011 224 4 438 447 10.1002/path.2922
49. Yang L., Belaguli N., Berger D. H., MicroRNA and colorectal cancer. World Journal of Surgery 2009 33 4 638 646 2-s2.0-62549134412 10.1007/s00268-008- 9865-5
50. Goel A., Boland C. R., Recent insights into the pathogenesis of colorectal cancer. Current Opinion in Gastroenterology 2010 26 1 47 52 2-s2.0-74249097210 10.1097/MOG.0b013e328332b850
51. Wong J. J. L., Hawkins N. J., Ward R. L., Colorectal cancer: a model for epigenetic tumorigenesis. Gut 2007 56 1 140 148 2-s2.0-33846008439 10.1136/gut.2005.088799 (Pubitemid 46044900)
52. Early D. S., Fontana L., Davidson N. O., Translational approaches to addressing complex genetic pathways in colorectal cancer. Translational Research 2008 151 1 10 16 2-s2.0-36448939776 10.1016/j.trsl.2007.09.002 (Pubitemid 350167043)
53. Kumar R., Commentary: targeting colorectal cancer through molecular biology. Seminars in Oncology 2005 32 9 S37 S39 2-s2.0-30544441704 10.1053/j.seminoncol.2005.06.012 (Pubitemid 43080913)
54. Winder T., Lenz H. J., Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer. Gastroenterology 2010 138 6 2163 2176 2-s2.0-77951643701 10.1053/j.gastro.2010. 02.005
55. Barton S., Starling N., Swanton C., Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapies. Current Cancer Drug Targets 2010 10 8 799 812
56. Pohl A., Zhang W., Ning Y., Manegold P. C., Lurje G., Lenz H. J., Targeting metastatic colorectal cancer in 2008: a long way from 5-FU. Oncology 2008 22 4 456 462 2-s2.0-45549086789
57. Cercek A., Saltz L., Evolving treatment of advanced colorectal cancer. Current Oncology Reports 2010 12 3 153 159 2-s2.0-77952243926 10.1007/s11912-010-0096-1
58. Kevans D., Wang L. M., Sheahan K., Epithelial-mesenchymal transition(EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status. International Journal of Surgical Pathology 2011 20 10 1 10
59. Zlobec I., Lugli A., Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget 2010 1 7 651 661
60. Zlobec I., Molinari F., Martin V., Mazzucchelli L., Saletti P., Trezzi R., de Dosso S., Vlajnic T., Frattini M., Lugli A., Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients. World Journal of Gastroenterology 2010 16 38 4823 4831 2-s2.0-78049495404 10.3748/wjg.v16.i38.4823
61. Itzkowitz S., Brand R., Jandorf L., Durkee K., Millholland J., Rabeneck L., Schroy P. C., Sontag S., Johnson D., Markowitz S., Paszat L., Berger B. M., A simplified, noninvasive Stool DNA test for colorectal cancer detection. American Journal of Gastroenterology 2008 103 11 2862 2870 2-s2.0-55349115380 10.1111/j.1572-0241.2008.02088.x
62. Brenner D. E., Rennert G., Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible? Journal of the National Cancer Institute 2005 97 15 1107 1109 2-s2.0-23244434445 10.1093/jnci/dji244 (Pubitemid 41511203)
63. Lenhard K., Bommer G. T., Asutay S., Schauer R., Brabletz T., Göke B., Lamerz R., Kolligs F. T., Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clinical Gastroenterology and Hepatology 2005 3 2 142 149 2-s2.0-13544257481 10.1016/S1542-3565(04)00624-X (Pubitemid 40220309)
64. Ahmed F. E., Vos P., IJames S., Lysle D. T., Allison R. R., Flake G., Sinar D. R., Naziri W., Marcuard S. P., Pennington R., Transcriptomic molecular markers for screening human colon cancer in stool and tissue. Cancer Genomics and Proteomics 2007 4 1 1 20 2-s2.0-33947215566 (Pubitemid 46426643)
65. Nair P., Lagerholm S., Dutta S., Shami S., Davis K., Ma S., Malayeri M., Coprocytobiology: on the nature of cellular elements from stools in the pathophysiology of colonic disease. Journal of Clinical Gastroenterology 2003 36 5 S84 S93 2-s2.0-0037404409 10.1097/00004836-200305001-00015 (Pubitemid 36459126)
66. Ahlquist D. A., Molecular detection of colorectal neoplasia. Gastroenterology 2010 138 6 2127 2139 2-s2.0-77951633198 10.1053/j.gastro.2010. 01.055
67. Itzkowitz S. H., Jandorf L., Brand R., Rabeneck L., Schroy P. C., Sontag S., Johnson D., Skoletsky J., Durkee K., Markowitz S., Shuber A., Improved fecal DNA test for colorectal cancer screening. Clinical Gastroenterology and Hepatology 2007 5 1 111 117 2-s2.0-33846214402 10.1016/j.cgh.2006.10.006 (Pubitemid 46096834)
68. Kanthan R., Senger J. L., Kanthan S. C., Fecal molecular markers for colorectal cancer screening. Gastroenterology Research & Practice 2012 2012 15 10.1155/2012/184343 184343
69. Greenwald B., The stool DNA test: an emerging technology in colorectal cancer screening. Gastroenterology Nursing 2005 28 1 28 32 2-s2.0-17844392073
70. Loganayagam A., Faecal screening of colorectal cancer. International Journal of Clinical Practice 2008 62 3 454 459 2-s2.0-38849121964 10.1111/j.1742-1241.2007.01532.x (Pubitemid 351197410)
71. Ahlquist D. A., Molecular stool screening for colorectal cancer. Using DNA markers may be beneficial, but large scale evaluation is needed. British Medical Journal 2000 321 7256 254 255 10.1136/bmj.321.7256.254
72. Berger B. M., Schroy P. C., Rosenberg J. L., Lai-Goldman M., Eisenberg M., Brown T., Rochelle R. B., Billings P. R., Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests. Clinical Colorectal Cancer 2006 5 5 338 343 2-s2.0-33244463533 (Pubitemid 43280063)
73. Creeden J., Junker F., Vogel-Ziebolz S., Rex D., Serum tests for colorectal cancer screening. Molecular Diagnosis and Therapy 2011 15 3 129 141 10.2165/11591300-000000000-00000
74. Kim M. S., Lee J., Sidransky D., DNA methylation markers in colorectal cancer. Cancer and Metastasis Reviews 2010 29 1 181 206 2-s2.0-77349107376 10.1007/s10555-010-9207-6